© 2005-2012 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.
Cancer.Net Associate Editor: Gynecologic Cancers
Cancer Treatment Centers of America
Maurie Markman, MD, is Senior Vice President of Clinical Affairs and National Director of Medical Oncology at Cancer Treatment Centers of America (CTCA). In addition to his national role within the organization, he also serves patients as a medical oncologist at CTCA at Eastern Regional Medical Center. Dr. Markman has more than 20 years of experience in cancer treatment and gynecologic research at some of the country's most recognized facilities. In June 2011, he received the esteemed ASCO Statesman Award. Presented annually, the Statesman Award recognizes individual ASCO members who have shown extraordinary volunteer service, dedication and commitment to ASCO, their hospital community and the patients they serve for at least 20 years.
Dedicated to finding new and innovative ways to treat cancer, Dr. Markman has published more than 250 peer-reviewed manuscripts, and more than 600 review articles, editorials, book chapters, letters and abstracts. He has also written or co-edited 10 books and served as an editorial board member on over 30 journals. He is currently the Editor-in-Chief of Current Oncology Reports. Dr. Markman is a member of numerous professional organizations, including, but not limited to: ASCO, the American College of Physicians the American Association for Cancer Research, the American Medical Association, the American Society of Hematology, the American Society of Internal Medicine, the International Gynecologic Cancer Society, and the Society of Gynecologic Oncologists.
Disclosure: In the past two years, Dr. Markman has received honoraria from Ortho Biotech, Lilly, Genentech, Cell Therapeutics, and Bristol-Myers Squibb; and served as a consultant/advisor for Lilly, Genentech, GlaxoSmithKline, Celgene, Cell Therapeutics, Ortho Biotech, Hana BioSciences, Eisai, Amgen, and Boehringer Ingelheim.
Last Updated: November 07, 2011